Abstract
ABSTRACT Introduction Neovascular age-related macular degeneration (AMD) is one of the most common causes of blindness among the elderly population. Treatment adherence requires frequent and sometimes unnecessary follow-up clinic visits that might contribute to physician, patient and caregiver burdens, especially, nowadays, when the elderly population is apprehensive about physically attending the ophthalmology clinic. Daily patient self-imaging with automated artificial intelligence-based OCT image analysis permits detailed characterization of the dynamics of fluid exudation and treatment response and facilitates treatment adherence. Metrics describing the temporal fluid volume dynamics may become important disease biomarkers. Home OCT telemedicine systems represent an alternative paradigm of disease monitoring; they may allow highly personalized retreatment decisions, with fewer unnecessary injections and clinic visits as well as well-founded selection of drug and drug delivery method. Areas covered This review will discuss recent progress in home OCT monitoring, its role in quantification of disease biomarkers, the mode of operation of these type of devices and what is required for such a system to operate successfully. Expert opinion In our opinion, various models of AI, machine learning and telemedicine will be implemented into medicine and will be feasible in the near future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.